CareLit · DOI-Nachweis · Geburtshilfe und Frauenheilkunde
Outpatient therapy of malignant ascites related to advanced gynecologic carcinomas with intraperitoneal application of the trifunctional antibody catumaxomab
DOI 10.1055/s-0034-1388473
Bibliografische Angaben
Nachweis in CareLit
Autor:innenCM Kurbacher, S Herz, O Horn, G Wessling, JA Kurbacher
ZeitschriftGeburtshilfe und Frauenheilkunde
Ausgabe09/2014
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Objectives: Catumaxomab (CATU) is a trifunctional antibody approved for the treatment (Tx) of malignant ascites (MA) related to EpCAM-positive tumors. CATU is mostly administered in a hospital. We report on our single-institution experience with outpatient CATU in patients (pts) with MA due to various gynecologic carcinomas. Methods: 26 patients were included: epithelial ovarian cancer (14), metastatic breast cancer…
Zitieren
Zitierempfehlung
CM Kurbacher, S Herz, O Horn, G Wessling, JA Kurbacher (2014) Outpatient therapy of malignant ascites related to advanced gynecologic carcinomas with intraperitoneal application of the trifunctional antibody catumaxomab. Geburtshilfe und Frauenheilkunde (09). https://doi.org/10.1055/s-0034-1388473
Mit CareLit weiterarbeiten